UF EFTI researchers surveyed American travelers to understand their travel intentions facing the recent coronavirus outbreak
A team of virologists who study viruses in bats work toward a test for a public health study to understand its development in older adults.
Patients with severe cases of COVID-19 who were treated with the investigational drug remdesivir recovered faster than those who did not take it, based on results released this week of an international clinical trial that included UF Health.
Computer simulations run by David A. Ostrov show three compounds appear to have the potential to block coronavirus from cells.
Seven University of Florida neuroscientists have earned Brain and Spinal Cord Injury Research Trust Bridge Funds.
UF/IFAS food safety experts answer your questions to debunk facts vs. myths on shopping safely for groceries.
As the COVID-19 pandemic continues to wreak havoc on the world, the resulting economic consequences are negatively affecting people and businesses alike. With unemployment rates rivaling that of the Great Depression and many businesses hanging ‘closed’ signs in their windows, people are struggling to make essential payments – a major one being their personal and business properties.
University of Florida economists now have a baseline understanding of ways the pandemic has affected the agriculture, aquaculture and marine sectors of Florida’s economy.
Three vaccines are now available to stem the pandemic, and for many, hope is increasing that a future free from the fear of COVID-19 is near.
A new study by University of Florida researchers aims to identify a drug or drugs that can potentially be used to prevent and/or treat infection with COVID-19.
The COVID-19 pandemic’s effect on education has prompted concern and debate among educators, students and parents as school districts nationwide wrestle over whether to reopen in the coming weeks and how to safely do so.
UF investigators participate in the first study to determine that the CoronaVac vaccine is 50% effective at preventing COVID-19 in Manaus, Brazil where the P.1 variant is widespread.